Consult with your pets veterinarian before administering this medication and follow their specific instructions for use
Some practitioners describe using it alongside a BPC-157/TB-500 stack during the later phases of healing when acute repair transitions to tissue remodeling and strengthening
Overall loss of muscle mass ranged from 32-45% and none of the 10 experimental treatment groups experienced any significant changes in muscle mass when administered treatment
DSIPs side effect profile appears mild compared to pharmaceutical sleep aids, with most reported effects relating to dose or timing issues rather than inherent toxicity
However, the main concern with oral delivery is bioavailability, or how much of the peptide is absorbed into the bloodstream after digestion
Sun (2021) a Chinese group working with APP/PS1 amyloid-pathology mice showed restoration of spatial learning with oral dosing (1.442.88 mg/kg, 3 months): neuron and synaptophysin counts rose, astrocyte and microglial activation fell, IL-1 and TNF- dropped and anti-inflammatory IL-10 increased